Corbus Pharmaceuticals Holdings, Inc.
CRBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595097
In the last 90 days, Corbus Pharmaceuticals Holdings, Inc. insiders filed 1 open-market purchase and 3 sales; 107 institutions reported holding it in 13F filings for Q2 2026, worth $129.1M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Corbus Pharmaceuticals Holdings, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 107 | 99 | −8 |
| Shares | 44.0M | 49.6M | +5.63M (+12.8%) |
| Value | $86.2M | $91.0M | +$4.78M (+5.6%) |
New holders (20)
Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 1,242,977 | $2.27M | 0.00% |
| Ergoteles LLC | 317,400 | $581.0K | 0.01% |
| Caption Management, LLC | 268,800 | $492.0K | 0.04% |
| Walleye Capital LLC | 168,824 | $309.0K | 0.01% |
| Tibra Equities Europe Ltd | 145,500 | $266.0K | 0.08% |
| Dimensional Fund Advisors LP | 65,794 | $120.0K | 0.00% |
| Platform Technology Partners | 60,000 | $110.0K | 0.05% |
| Walleye Trading LLC | 56,659 | $104.0K | 0.00% |
| JTC Employer Solutions Trusteee Ltd | 33,185 | $61.0K | 0.01% |
| LMR Partners LLP | 29,228 | $53.0K | 0.00% |
| Two Sigma Securities, LLC | 23,339 | $43.0K | 0.01% |
| Jump Financial, LLC | 23,466 | $43.0K | 0.00% |
| Westwood Holdings Group Inc. | 19,933 | $37.0K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 20,467 | $37.0K | 0.01% |
| Graypoint LLC | 13,420 | $25.0K | 0.00% |
| McAdam, LLC | 10,005 | $14.0K | 0.00% |
| Parisi Gray Wealth Management | 1,087 | $2.00K | 0.00% |
| FMR LLC | 1 | $0 | 0.00% |
| O'Shaughnessy Asset Management, LLC | 100 | $0 | 0.00% |
| Berman Capital Advisors, LLC | 308 | $0 | 0.00% |
Sold out (28)
Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.